{"id":"https://openalex.org/W4396568819","doi":"https://doi.org/10.1158/2643-3230.c.7209152.v1","title":"Data from Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119","display_name":"Data from Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119","publication_year":2024,"publication_date":"2024-05-01","ids":{"openalex":"https://openalex.org/W4396568819","doi":"https://doi.org/10.1158/2643-3230.c.7209152.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2643-3230.c.7209152.v1","doi":"https://doi.org/10.1158/2643-3230.c.7209152.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2643-3230.c.7209152.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/2643-3230.c.7209152.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069712978","display_name":"Thomas K\u00f6hnke","orcid":"https://orcid.org/0000-0001-7454-6282","observed_orcids":["https://orcid.org/0000-0001-7454-6282"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas K\u00f6hnke","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7454-6282","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047959847","display_name":"Kevin A. Nuno","orcid":"https://orcid.org/0000-0002-2677-1319","observed_orcids":["https://orcid.org/0000-0002-2677-1319"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin A. Nuno","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2677-1319","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048705445","display_name":"Catherine C. Alder","orcid":"https://orcid.org/0000-0002-8265-6147","observed_orcids":["https://orcid.org/0000-0002-8265-6147"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine C. Alder","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8265-6147","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057316768","display_name":"Eric J. Gars","orcid":"https://orcid.org/0000-0002-0712-006X","observed_orcids":["https://orcid.org/0000-0002-0712-006X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric J. Gars","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0712-006X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051785171","display_name":"Paul Phan","orcid":"https://orcid.org/0000-0002-1250-4834","observed_orcids":["https://orcid.org/0000-0002-1250-4834"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Phan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1250-4834","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042159998","display_name":"Amy C. Fan","orcid":"https://orcid.org/0000-0003-1612-1862","observed_orcids":["https://orcid.org/0000-0003-1612-1862"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy C. Fan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1612-1862","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5074919402","display_name":"Ravindra Majeti","orcid":"https://orcid.org/0000-0002-5814-0984","observed_orcids":["https://orcid.org/0000-0002-5814-0984"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ravindra Majeti","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5814-0984","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10222","display_name":"Genomics and Chromatin Dynamics","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/asxl1-mutation","display_name":"ASXL1 mutation","score":0.8889999985694885},{"id":"https://openalex.org/keywords/clonal-hematopoiesis","display_name":"clonal hematopoiesis","score":0.9229999780654907},{"id":"https://openalex.org/keywords/myeloid-neoplasms","display_name":"myeloid neoplasms","score":0.9649999737739563},{"id":"https://openalex.org/keywords/deubiquitination","display_name":"deubiquitination","score":0.972000002861023},{"id":"https://openalex.org/keywords/polycomb-repressive-complex-1","display_name":"PRC1","score":0.859000027179718},{"id":"https://openalex.org/keywords/hematopoietic-stem-and-progenitor-cells","display_name":"hematopoietic stem and progenitor cells","score":0.9079999923706055},{"id":"https://openalex.org/keywords/chromatin-accessibility","display_name":"chromatin accessibility","score":0.7139999866485596},{"id":"https://openalex.org/keywords/therapeutic-vulnerabilities","display_name":"therapeutic vulnerabilities","score":0.48100000619888306},{"id":"https://openalex.org/keywords/disease-models","display_name":"disease models","score":0.3970000147819519}],"concepts":[{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.7045856714248657},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.6883422136306763},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5466353297233582},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4278596043586731},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.35114026069641113},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20162034034729004},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.07718360424041748}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2643-3230.c.7209152.v1","doi":"https://doi.org/10.1158/2643-3230.c.7209152.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2643-3230.c.7209152.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2643-3230.c.7209152.v1","doi":"https://doi.org/10.1158/2643-3230.c.7209152.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2643-3230.c.7209152.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4391839359","https://openalex.org/W2997542224","https://openalex.org/W2903402165","https://openalex.org/W4405126139","https://openalex.org/W2591832628","https://openalex.org/W2928779381","https://openalex.org/W2980250989","https://openalex.org/W1992320498","https://openalex.org/W1976913227","https://openalex.org/W2811305839"],"abstract_inverted_index":{"Abstract":[0],"Mutations":[1],"in":[2,13,17,66,136],"additional":[3],"sex":[4],"combs":[5],"like":[6],"1":[7],"(ASXL1)":[8],"confer":[9],"poor":[10],"prognosis":[11],"both":[12,98,137],"myeloid":[14,60,99,141,153],"malignancies":[15],"and":[16,35,77,95,100,118,140,152,169],"premalignant":[18,138],"clonal":[19],"hematopoiesis":[20],"(CH).":[21],"However,":[22],"the":[23,52,70,87,127],"mechanisms":[24],"by":[25],"which":[26],"these":[27],"mutations":[28,65],"contribute":[29],"to":[30,58,69,83,113,122,165,174],"disease":[31,48,53],"initiation":[32],"remain":[33],"unresolved,":[34],"mutation-specific":[36],"targeting":[37],"has":[38],"remained":[39],"elusive.":[40],"To":[41],"address":[42],"this,":[43],"we":[44,106,159],"developed":[45],"a":[46,73,147],"human":[47,157],"model":[49],"that":[50,64,79,108,124,161],"recapitulates":[51],"trajectory":[54],"from":[55],"ASXL1-mutant":[56],"CH":[57,139,151],"lethal":[59],"malignancy.":[61,142,154],"We":[62],"demonstrate":[63,107,123],"ASXL1":[67,81,115,145,163],"lead":[68],"expression":[71,116],"of":[72,86,97,126,150,167],"functional,":[74],"truncated":[75,80,114,162],"protein":[76],"determine":[78,160],"leads":[82,164],"global":[84],"redistribution":[85,166],"repressive":[88],"chromatin":[89],"mark":[90],"H2AK119Ub,":[91],"increased":[92],"transposase-accessible":[93],"chromatin,":[94],"activation":[96],"stem":[101],"cell":[102],"gene-expression":[103],"programs.":[104],"Finally,":[105],"H2AK119Ub":[109,168],"levels":[110,117],"are":[111],"tied":[112],"leverage":[119],"this":[120],"observation":[121],"inhibition":[125],"PRC1":[128,175],"complex":[129],"might":[130],"be":[131],"an":[132],"ASXL1-mutant\u2013specific":[133],"therapeutic":[134,172],"vulnerability":[135,173],"Significance:":[143],"Mutant":[144],"is":[146],"common":[148],"driver":[149],"Using":[155],"primary":[156],"HSPCs,":[158],"may":[170],"affect":[171],"inhibition.":[176]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2024-05-02T00:00:00"}
